Skip NavigationSkip to Content

Structural basis of peptidoglycan endopeptidase regulation

  1. Author:
    Shin, Jung-Ho [ORCID]
    Sulpizio, Alan G [ORCID]
    Kelley, Aaron [ORCID]
    Alvarez, Laura [ORCID]
    Murphy, Shannon G
    Fan,Lixin
    Cava, Felipe [ORCID]
    Mao, Yuxin [ORCID]
    Saper, Mark A [ORCID]
    Dörr, Tobias [ORCID]
  2. Author Address

    Weill Institute for Cell and Molecular Biology, Cornell University, Ithaca, NY 14853., Department of Biological Chemistry, University of Michigan, Ann Arbor, MI 48109-5606., The Laboratory for Molecular Infection Medicine Sweden, Department of Molecular Biology, Ume 229; University, SE-901 87 Ume 229;, Sweden., Department of Microbiology, Cornell University, Ithaca, NY 14853., Basic Science Program, Frederick National Laboratory for Cancer Research, SAXS Core Facility of the National Cancer Institute, Frederick, MD 21702., Weill Institute for Cell and Molecular Biology, Cornell University, Ithaca, NY 14853; tdoerr@cornell.edu., Cornell Institute of Host-Microbe Interactions and Disease, Cornell University, Ithaca, NY 14853.,
    1. Year: 2020
    2. Date: MAY 26
    3. Epub Date: 2020 05 11
  1. Journal: Proceedings of the National Academy of Sciences of the United States of America
    1. 117
    2. 21
    3. Pages: 11692-11702
  2. Type of Article: Article
  3. ISSN: 0027-8424
  1. Abstract:

    Most bacteria surround themselves with a cell wall, a strong meshwork consisting primarily of the polymerized aminosugar peptidoglycan (PG). PG is essential for structural maintenance of bacterial cells, and thus for viability. PG is also constantly synthesized and turned over; the latter process is mediated by PG cleavage enzymes, for example, the endopeptidases (EPs). EPs themselves are essential for growth but also promote lethal cell wall degradation after exposure to antibiotics that inhibit PG synthases (e.g., ß-lactams). Thus, EPs are attractive targets for novel antibiotics and their adjuvants. However, we have a poor understanding of how these enzymes are regulated in vivo, depriving us of novel pathways for the development of such antibiotics. Here, we have solved crystal structures of the LysM/M23 family peptidase ShyA, the primary EP of the cholera pathogen Vibrio cholerae Our data suggest that ShyA assumes two drastically different conformations: a more open form that allows for substrate binding and a closed form, which we predicted to be catalytically inactive. Mutations expected to promote the open conformation caused enhanced activity in vitro and in vivo, and these results were recapitulated in EPs from the divergent pathogens Neisseria gonorrheae and Escherichia coli Our results suggest that LysM/M23 EPs are regulated via release of the inhibitory Domain 1 from the M23 active site, likely through conformational rearrangement in vivo.

    See More

External Sources

  1. DOI: 10.1073/pnas.2001661117
  2. PMID: 32393643
  3. WOS: 000536797100066
  4. PII : 2001661117

Library Notes

  1. Fiscal Year: FY2019-2020
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel